Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in PGEN — Precigen, Inc.

CIK 1423053 MIAMI, FL
Back to PGEN Full portfolio

Position in PGEN

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$4,676,217
-$5,782,005 QoQ
Shares Held
820,389
-69.6% QoQ
Ownership
0.229%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 210 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PGEN Over Time

Shares Held

Position Value (USD)

Derivatives in PGEN

reported options exposure · as of Jun 30, 2026
CallValue
$869,250
CallShares
152,500
PutValue
$412,110
PutShares
72,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,758,606 across 435 Biotechnology names. PGEN ranks #142 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in PGEN

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $869,250 152,500
2026-06-30 $412,110 72,300
2026-06-30 $4,676,217 820,389
2026-03-31 $924,156 238,800
2026-03-31 $236,457 61,100
2026-03-31 $10,458,222 2,702,383
2025-12-31 $225,302 53,900
2025-12-31 $1,600,104 382,800
2025-12-31 $13,583,679 3,249,684
2025-09-30 $841,911 255,900
2025-09-30 $1,689,086 513,400
2025-09-30 $8,869,283 2,695,831
2025-06-30 $176,932 124,600
2025-06-30 $104,512 73,600
2025-06-30 $447,021 314,804
2025-03-31 $12,814 8,600
2025-03-31 $162,261 108,900
2024-12-31 $5,376 4,800
2024-12-31 $79,968 71,400
2024-09-30 $81,035 85,300
2024-09-30 $28,025 29,500
2024-09-30 $363,849 382,999
2024-06-30 $123,556 78,200
2024-06-30 $24,016 15,200
2024-06-30 $663,214 419,756
2024-03-31 $89,030 61,400
2024-03-31 $32,190 22,200
2024-03-31 $460,021 317,256
2023-12-31 $18,760 14,000
2023-12-31 $712,236 531,520
2023-12-31 $14,472 10,800
2023-09-30 $16,330 11,500
2023-09-30 $421,458 296,802
2023-09-30 $19,312 13,600
2023-06-30 $32,890 28,600
2023-06-30 $50,140 43,600
2023-06-30 $28,611 24,880
2023-03-31 $42,930 40,500
2023-03-31 $606,339 572,018
2023-03-31 $70,172 66,200
2022-12-31 $122,056 80,300
2022-12-31 $83,752 55,100
2022-12-31 $761,677 501,104
2022-09-30 $1,094,458 516,254
2022-09-30 $56,392 26,600
2022-09-30 $162,392 76,600
2022-06-30 $83,080 62,000
2022-06-30 $1,090,309 813,664
2022-06-30 $51,054 38,100
2022-03-31 $1,397,520 662,332